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A Systematic Survey of Carbonic Anhydrase
mRNA Expression During Mammalian Inner
Ear Development
Ling Wu,1,2,3 Borum Sagong,4 Jae Young Choi,1,3 Un-Kyung Kim,4 and Jinwoong Bok1,2,3*
Background: Carbonic anhydrases (CAs), which catalyze CO2 hydration to bicarbonate and protons, have been
suggested to regulate potassium homeostasis and endocochlear potential in the mammalian cochlea. Sixteen
mammalian CA isozymes are currently known. To understand the specific roles of CA isozymes in the inner
ear, a systematic survey was conducted to reveal temporal and spatial expression patterns of all 16 CA iso-
zymes during inner ear development. Results: Our quantitative reverse transcriptase-polymerase chain reac-
tion results showed that different tissues express unique combinations of CA isozymes. During inner ear
development, transcripts of four cytosolic isozymes (Car1, Car2, Car3, and Car13), two membrane-bound iso-
zymes (Car12 and Car14), and two CA-related proteins (Car8 and Car11) were expressed at higher levels than
other isozymes. Spatial expression patterns of these isozymes within developing inner ears were determined
by in situ hybridization. Each isozyme showed a unique expression pattern during development. For example,
Car12 and Car13 expression closely overlapped with Pendrin, an anion exchanger, while Car2 overlapped with
Na-K-ATPase in type II and IVotic fibrocytes, suggesting functional relationships in the inner ear. Conclusions:
The temporal and spatial expression patterns of each CA isozyme suggest unique and differential roles in
inner ear development and function.Developmental Dynamics 242:269–280, 2013.VC 2012 Wiley Periodicals, Inc.
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Key findings:
 A systematic survey for transcripts of all 16 mammalian carbonic anhydrase isozymes in various organs
showed that each organ expresses unique combinations of carbonic anhydrase isozymes.
 During inner ear development, transcripts of four cytosolic isozymes (Car1, Car2, Car3, and Car13), two mem-
brane-bound isozymes (Car12 and Car14), and two CA-related proteins (Car8 and Car11) were expressed at
higher levels than other isozymes.
 Each isozyme showed a unique temporal and spatial expression pattern during inner ear development.
 Expression patterns for some isozymes closely overlapped with genes previously associated with inner ear de-
velopment or function, such as Pendrin, Pou3f4, or Bmp4.
Accepted 3 December 2012
INTRODUCTION
Carbonic anhydrases (CAs) are zinc-
containing metalloenzymes that
catalyze the reversible conversion of
carbon dioxide to bicarbonate ion and
a proton. These enzymes, found in all
types of organisms, are encoded by
five independent gene families: the a-,
b-, g-, d-, and e-CAs (Supuran, 2008b;
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Xu et al., 2008). Only a-CA family
members have been identified in
mammals (Henry and Swenson, 2000;
Esbaugh and Tufts, 2006). Thus far,
16 a-CA isozymes have been
described, with different catalytic
activities and subcellular localiza-
tions: CAI, II, III, VII, and XIII are
cytoplasmic; CAIV, IX, XII, XIV, and
XV are membrane-bound; CAVa and
Vb are mitochondrial; and CAVI is
secreted (Supuran, 2008a,b). CAVIII,
X, and XI are called CA-related pro-
teins (CA-RPs) because they lack clas-
sical CA enzymatic activity and their
biological functions remain unclear.
The importance of carbonic anhy-
drases has been shown in many phys-
iological and pathological processes,
including pH and CO2 homeostasis,
electrolyte secretion, respiration,
CO2/HCO3
 transport, and bone
resorption and calcification (Supuran,
2008a). In the respiratory system,
CAs are involved in most CO2 trans-
port and excretion from metabolically
active tissues to red blood cells, and
finally to gas exchanging organs, such
as the lungs (Henry and Swenson,
2000). Cytoplasmic CAI and II are the
most abundant CA isozymes in the
red blood cells, while both cytoplasmic
(CAII) and membrane-bound CAs
(CAIV) are found in the lung (Henry
and Swenson, 2000; Esbaugh and
Tufts, 2006). The role of CAs has also
been studied in detail in regulating
renal physiology, such as acid/base
homeostasis and bicarbonate reab-
sorption (Purkerson and Schwartz,
2007). CAs are expressed in most kid-
ney segments. Cytoplasmic CAII
accounts for most CA activity in the
kidney, and different combinations of
membrane-bound CAs, including
CAIV, CAXII, CAXIV, and CAXV, are
also expressed in different species
(Purkerson and Schwartz, 2007).
CAII is involved in bone physiology,
such as osteoclast differentiation and
bone resorption, and CAII-deficiency
leads to osteopetrosis in humans and
mice (Sly and Hu, 1995; Lehenkari
et al., 1998; Margolis et al., 2008). In
addition, various CAs expressed in
the gastrointestinal canal and diges-
tive glands are involved in ammonia
detoxification, saliva production, gas-
tric acid production, bile production,
pancreatic juice production, and in-
testinal ion transport (Pan et al.,
2007; Supuran, 2008a). Mitochondrial
CAV has been associated with molecu-
lar signaling, such as insulin secre-
tion in pancreatic b cells (Parkkila
et al., 1998). Some CA isozymes are
down- or up-regulated in various
tumors and have been associated with
oncogenesis and tumor progression
(Supuran, 2008a,b). Consistently, two
hypoxia-inducible CA isozymes, CAIX
and XII, were shown to promote tu-
mor growth by regulating pH in an
acidic and hypoxic microenvironment
(Jarvela et al., 2008; Chiche et al.,
2009). In the brain, CAIV and XIV
were shown to regulate pH in extrac-
ellular fluid (Shah et al., 2005).
Lastly, CAIII, which is highly
expressed in many tissues, including
skeletal muscle, has relatively low CA
activity. Its physiological role is
unclear because mice lacking CAIII
do not have noticeable anatomical or
physiological abnormalities (Kim
et al., 2004). CAIII can, however, pro-
tect cells from oxidative damage by S-
glutathiolation on two cysteine resi-
dues in response to oxidative stress,
thereby functioning as an oxyradical
scavenger (Raisanen et al., 1999; Mal-
lis et al., 2002, 2000; Gailly et al.,
2008).
CA activity in the inner ears has
been demonstrated biochemically by
visualizing CO2 hydration in guinea
pigs, cats, and chinchillas (Erulkar
and Maren, 1961; Lim et al., 1983;
Hsu and Nomura, 1985; Okamura
et al., 1996). Although the specific
location of CA activity in the inner
ear differs slightly depending on the
species and detection method, CA ac-
tivity is present in the organ of Corti,
outer sulcus cells and their associated
root processes, otic fibrocytes in the
spiral ligament, as well as spiral gan-
glion neurons. Consistently, immuno-
histochemical studies have detected
CAII and CAIII immunoreactivity in
the otic fibrocytes, spiral limbus, and
Reissner’s membrane in gerbil,
guinea pig, and human cochlea, with
slight differences among species and
detection methods.
The role of CA activity in the inner
ear was first suggested by Erulkar
and Maren (Erulkar and Maren,
1961). In cat inner ears, CA activity is
distributed along the cochlear duct,
with the highest concentrations in the
apical turn, progressively lower con-
centrations toward the basal turns,
and lowest concentrations in the ves-
tibule (Erulkar and Maren, 1961).
Administering intravenous acetazol-
amide, a specific CA inhibitor, consid-
erably reduced the perilymph and
endolymph volumes and pressures,
and eliminated the high potassium
concentration in the endolymph
(Erulkar and Maren, 1961). Consis-
tently, inhibiting CA activity affects
the generation of endocochlear poten-
tial in guinea pigs and rats, suggest-
ing a critical role of CA activity in the
sound transduction (Prazma, 1978;
Sterkers et al., 1984; Ikeda et al.,
1987). Furthermore, CA activity has
also been associated with normal oto-
lith (otoconia) development in mice,
chicken, and fish (Purichia and
Erway, 1972; Kido et al., 1991; Tohse
et al., 2004).
Despite the critical roles in the au-
ditory and vestibular functions, no
systematic study has been conducted
to determine the expression patterns
of all known CA isozymes in the mam-
malian inner ear. Although CAII and
III localization have been described in
some cochlear regions (Spicer and
Schulte, 1991; Ichimiya et al., 1994;
Weber et al., 2001), they do not
account for all CA activities in the
inner ear (Erulkar and Maren, 1961;
Lim et al., 1983; Hsu and Nomura,
1985; Okamura et al., 1996). In this
study, we examined the temporal and
spatial expression of all known CA
isozymes by quantitative real-time
polymerase chain reaction (qRT-PCR)
and in situ hybridization in mouse
embryonic and postnatal inner ears.
Our study provides comprehensive
expression profiles for the CA iso-
zymes and their potential role in
inner ear development and function.
RESULTS AND DISCUSSION
Expression Profiles of
Carbonic Anhydrases in
Various Tissues in Mice
The expression levels of all known CA
isozymes were analyzed by semi-
quantitative reverse transcriptase
PCR (RT-PCR) of RNAs isolated from
various tissues, including inner ear,
brain, kidney, and liver of 3-week-old
mice (Fig. 1A). In the inner ear, tran-
scripts of four cytosolic isozymes
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(Car1, Car2, Car3, and Car13) and a
membrane-bound isozyme (Car14)
were expressed at higher levels than
the other isozymes. In the brain,
transcripts of two cytosolic isozymes
(Car2 and Car7) and two membrane-
bound isozymes (Car4 and Car14)
were strongly expressed. In addition,
transcripts of three acatalytic CA-
related proteins (CA-RPs) (Car8,
Car10, and Car11) were also
expressed. In the kidney, transcripts
of a cytosolic isozyme (Car2), four
membrane-bound isozymes (Car4,
Car12, Car14, and Car15), and a mi-
tochondrial isozyme (Car5b) were
expressed relatively strongly. In the
liver, two cytosolic isozymes (Car2
and Car3), a mitochondrial isozyme
(Car5a), a membrane-bound isozyme
(Car14), and a CA-RP (Car8), were
expressed. These results showed that
each tissue expresses a unique com-
bination of CA isozymes, although
some isozymes, such as Car2 and
Car14, appear to be ubiquitous.
Temporal Expression of
Carbonic Anhydrases During
Inner Ear Development
To determine temporal expression
patterns of CAs during inner ear de-
velopment, we performed qRT-PCR at
embryonic day (E) 15.5, postnatal day
(P) 0, P5, and P21 (Fig. 1B–D). Con-
sistent with the semi-quantitative
RT-PCR (Fig. 1A), Car1, Car2, Car3,
Car13, and Car14 showed relatively
high expression at P21 (Fig. 1B,C). In
Fig. 1. Expression of CA transcripts in various tissues and during inner ear development. A: Expression of all 16 CA isozyme transcripts was an-
alyzed by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) in inner ear, brain, kidney, and liver from P21 mice. Total
cDNA extracted from the whole body of postnatal day (P) 8 mouse embryo was used as a positive control. B–D: Temporal expression patterns of
each CA isozyme during inner ear development were analyzed by quantitative real-time PCR. Please refer to the text for details.
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Fig. 2. Expression patterns of Car1, Car2, and Car3 in the developing mouse inner ear. A: Car1 was expressed in bone marrow of the otic cap-
sule in the cochlea (A0, arrows) and vestibule (A00) at P21. B: At embryonic day (E) 15.5, Car2 was expressed in the mesenchyme surrounding the
cochlea and vestibule (bracket), but not in the entire periotic mesenchyme, indicated by Pou3f4 expression C:. Weak epithelial expression was
found in the outer sulcus (B0, B00, bracket), GER (arrowhead), and basilar membrane (arrow). E: At postnatal day (P) 5, Car2 was weakly expressed
in otic fibrocytes, stria vascularis (arrowheads), otic capsule (white arrows), basilar membrane (black arrow), and inner sulcus (bracket). D: At P21,
Car2 was strongly expressed in type II and IV fibrocytes (D0, bracket) and bone marrow (D, bracket; D0, white arrows). Car2 was also weakly
expressed in type I fibrocytes and the organ of Corti, likely in the outer hair cells (D0, asterisk). F: Car3 was initially expressed near the presumptive
stria vascularis at E15.5 (F,F0, asterisk), expanded to the entire spiral ligament at P5 (G,G0), and restricted to type I, III, and V fibrocytes at P21
(H,H0, asterisk). Car3 expression was also found in the otic capsule (G,H, brackets) and modiolus (G, arrow), which is comparable to Osteocalcin
(OCN) (I, arrow). Scale bar in A applies to B,D, and F–I; the scale bar in A0 applies to B0, D0, E, and F0–H0; the scale bar in A00 applies to B00.
addition, our qRT-PCR data showed
that Car8, Car11, and Car12 were
also expressed at moderate levels dur-
ing inner ear development (Fig. 1C),
while the remaining isozymes (Car4,
Car5a, Car5b, Car6, Car7, Car9,
Car10, and Car15) were expressed at
undetectable or extremely low levels
(Fig. 1D).
Car3 was strongly expressed in the
inner ears throughout developmental
stages, suggesting an important role
of Car3 in inner ear development and
function. Interestingly, acatalytic CA-
RPs, such as Car8 and Car11, were
also expressed at moderate levels in
developing inner ears, although Car8
became undetectable in the mature
inner ear at P21 (Fig. 1C). These
results suggest that CA isozymes may
play specific roles in different stages
of inner ear development.
Spatial Expression Patterns
of Carbonic Anhydrases
During Inner Ear
Development
The localization of expression for each
CA transcript was determined by in
situ hybridization in developing
(E15.5, P0, P5) and mature (P21)
inner ears.
Abundant cytosolic isozymes,
Car1 and Car2
Consistent with qRT-PCR results
(Fig. 1), Car1 transcripts were barely
detectable in the inner ear during em-
bryonic and postnatal development
(E15.5, P0, and P5; data not shown)
and were present in the bone marrow
of the otic capsule at P21 (Fig. 2A–A00,
arrows). Recently, it has been shown
that CAI is associated with ankylos-
ing spondylitis, characterized by
abnormal bone formation, in humans
and CAI function is involved in bone
formation in vitro (Chang et al.,
2012).
Car2 transcripts were expressed in
mesenchymal cells adjacent to the
stria vascularis, spiral limbus, and
basilar membrane (Fig. 2B). Weak
Car2 expression was also present in
epithelial cells in the outer sulcus and
greater epithelial ridge (GER) (Fig.
2B0,B00, bracket and arrowhead). This
broad Car2 expression continued dur-
ing neonatal development (Fig. 2E),
but by P21, Car2 expression was
mainly present in type II and IV otic
fibrocytes (Fig. 2D0, bracket) and bone
marrow of the otic capsule (Fig. 2D0,
white arrows). Weaker Car2 expres-
sion was present in type I fibrocytes,
the apical and basal margins of stria
vascularis (arrowheads), and outer
hair cells in the organ of Corti (aster-
isk) at P21. In the vestibules, weak
and broad Car2 expression was pres-
ent in mesenchymal tissues surround-
ing the sensory organs at E15.5 (Fig.
2B, bracket), and stronger expression
in the otic capsule at P5, and bone
marrows at P21 (Fig. 2D, brackets).
Previously, CAII immunoreactivity
has been detected in type I, III, and
IV otic fibrocytes in the spiral liga-
ment of the gerbil cochlea (Spicer and
Schulte, 1991) and in type I, II, and
IV fibrocytes in guinea pigs (Ichimiya
et al., 1994). These expression pat-
terns differ slightly from our results,
which show strong Car2 expression in
type II and IV fibrocytes (Fig. 2). This
difference could be due to different
species or detection methods.
Potential role of Car3 as a free
radical scavenger in otic
fibrocytes
Initially, Car3 expression was closely
associated with prospective type I otic
fibrocytes at E15.5 (Fig. 2F,F0, aster-
isk), but gradually expanded to the
entire spiral ligament, encompassing
all types of otic fibrocytes by P5 (Fig.
2G,G0), and later restricted to type I,
III, and V otic fibrocytes at P21 (Fig.
2H,H0, asterisk). Interestingly, Car3
expression in the cochlear lateral wall
at P21 was complementary to Car2,
that is Car3 was more abundant in
type I and III fibrocytes while Car2
was stronger in type II and IV fibro-
cytes (Fig. 2D0,H0, asterisk and brack-
ets). Weak Car3 expression was also
detected in the otic capsule (Fig.
2G0,H0, arrows) and bony modiolus
area at P5 (Fig. 2G,I, arrows), which
disappeared by P21 (Fig. 2H, arrow).
Car3 expression was also present in
the vestibular mesenchymal regions
throughout development (Fig. 2F–H,
brackets). Consistent with our data,
CAIII immunoreactivity was also
present in type I and III fibrocytes
from human and gerbil cochlea
(Spicer and Schulte, 1991; Weber
et al., 2001).
Unlike the other isozymes, CAIII
has relatively little CA activity
(Sanyal et al., 1982; Engberg et al.,
1985), but mainly functions as an oxy-
radical scavenger and protects cells
from oxidative damage by S-gluta-
thiolation on two cysteine residues in
response to oxidative stress (Raisanen
et al., 1999; Mallis et al., 2002, 2000;
Gailly et al., 2008). Nevertheless,
introducing CAIII into hepatocellular
carcinoma cells accelerated the speed
at which culture medium was acidi-
fied, suggesting that CAIII can still
catalyze carbon dioxide hydration,
although at a reduced rate (Dai et al.,
2008). The in vivo function of CAIII is
unclear because Car3 null mutants do
not display obvious anatomical or
physiological abnormalities (Kim
et al., 2004). A recent study, however,
showed that a lack of CAIII function
attenuates ATP synthesis by mito-
chondria in skeletal muscle, although
its underlying mechanism is unclear
(Liu et al., 2007). Therefore, CAIII
may play dual roles in otic fibrocytes:
facilitating mitochondrial ATP syn-
thesis as well as detoxifying free radi-
cals resulting from active ATP
synthesis.
Possible Functional Association
of Car12 and Car13 With
Pendrin
Car12 was expressed at P0 in regions
that would become the outer sulcus
and spiral prominence (Fig. 3A,A0,
bracket). By P5, Car12 expression in
the outer sulcus had expanded to the
associated root cell processes, con-
tinuing to P21 (Fig. 3B,I, brackets).
Car12 was also expressed in the endo-
lymphatic duct at E15.5 (Fig. 3C).
These Car12 expression patterns
closely overlap with expression of
Pendrin, an anion exchanger that
transports Cl, I, formate, and
HCO3
 (Fig. 3D–F) (Everett et al.,
1999; Wangemann et al., 2004). Car12
was also weakly expressed in the spi-
ral ganglion in the postnatal cochlea
(Fig. 3A, arrows; data not shown) and
also in Boettcher’s cells at P21 (Fig.
3I, arrow). In addition, Car12 was
strongly expressed in the vestibular
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hair cells of cristae and maculae (Fig.
3G,H), but not in the auditory hair
cells of the organ of Corti in the coch-
lea (Fig. 3I, asterisk).
Car13 transcripts were observed in
the lesser epithelial ridge (LER) area
of E15.5 cochlea, which closely over-
laps with Bmp4 expression (Fig.
3J,M, brackets) (Hwang et al., 2010).
At P0, Car13 expression was
restricted to the epithelial cells of the
spiral prominence and outer sulcus,
with faint expression in prospective
type III fibrocytes (Fig. 3K, bracket,
arrowheads), which was maintained
until P21 (Fig. 3L, bracket and arrow-
heads; data not shown). In the vesti-
bule, weak Car13 expression was
observed in the mesenchymal tissues
along the otic capsule at E15.5 and
P5, which is similar with the Car13
expression pattern in the type III
fibrocytes of the cochlea (Fig.
3K,L,N,O, arrows).
Previously, cytosolic and mem-
brane-bound CAs have been shown to
associate directly with ion transport-
ers, forming a membrane protein com-
plex called a biocarbonate transport
metabolon. This complex can
Fig. 3. Expression of Car12 and Car13 in the developing mouse inner ear. A,B: Car12 was expressed in the spiral prominence and associated
root cell processes (brackets) and also in the spiral ganglion (arrows). C: Car12 was expressed in the endolymphatic duct at embryonic day (E)
15.5. D–F: Car12 expression closely overlapped with Pendrin. G–I: At P21, Car12 was expressed in the spiral prominence and associated root cell
processes (I, bracket). In addition, Car12 was also expressed in hair cells of cristae (G) and maculae (H) and Boettcher’s cells (I, arrow), but not in
hair cells of organ of Corti in the P21 cochlea (I, asterisk). J–M: Car13 was weakly expressed on the lateral side of the lesser epithelial ridge (LER)
(brackets), similar to Bmp4 (M) at E15.5. Car13 was also expressed in the spiral prominence and presumptive outer sulcus during neonatal devel-
opment (brackets). N,O: Car13 was weakly expressed in prospective type III fibrocytes during neonatal stages (K,L, arrowheads) and in the mes-
enchymal tissues along the otic capsule at E15.5 and P5 (N,O, arrowheads). Scale bar in A applies to D; the scale bar in A0 applies to B–C, D0, E–
H, and J–O.
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significantly enhance Hþ/HCO3

transport by mass CA action supply-
ing and dissipating the reaction prod-
ucts (Alvarez et al., 2003; Purkerson
and Schwartz, 2007). For example, in
the renal tube, a cytosolic CAII and a
membrane-bound CAIV form trans-
port metabolons with bicarbonate
transporters such as AE1, NBC1,
NBC3, and SCL26A6 and a proton
antiporter such as NHE1 (Purkerson
and Schwartz, 2007).
Based on expression of the tran-
scripts of membrane-bound Car12, cy-
tosolic Car13, and the anion
exchanger Pendrin in the outer sulcus
and root cell processes, it is possible
that CAXII and CAXIII may physi-
cally associate with Pendrin or other
transporters to form metabolons in
the outer sulcus and root cell proc-
esses and regulate ion and pH homeo-
stasis of endolymphatic fluid. Consis-
tently, the unique biochemical proper-
ties of CAXIII, which catalyzes CO2
hydration even in the presence of
high HCO3
 concentrations, suggests
that CAXIII may form metabolons in
tissues that require tight bicarbonate
regulation. For example, the female
reproductive tract requires an alka-
line environment to maintain sperm
motility (Innocenti et al., 2004).
Further experiments should examine
whether CAXII and CAXIII indeed
physically or functionally associate
with Pendrin to regulate endolymph
homeostasis.
A membrane-bound isozyme
Car14
Car14 was broadly expressed in both
epithelial and mesenchymal tissues
in the cochlea at P0 (Fig. 4A,A0). At
P5, Car14 expression was stronger in
the otic fibrocytes, stria vascularis,
and supporting cells in the organ of
Corti (Fig. 4B,B0). Car14 expression
was maintained in the otic fibrocytes
and greatly reduced in the stria vas-
cularis at P21 (Fig. 4C). Car14
expression in Reissner’s membrane at
P0 decreased by P5 (Fig. 4A0,B, white
arrow). Car14 expression in the organ
of Corti at P5 appeared to be in pillar
cells and Deiters’ cells when com-
pared with Smpx, a hair cell-specific
gene (Fig. 4B0) (Yoon et al., 2011). At
P21, Car14 expression was observed
in the inner phalangeal cells and
inner pillar cells located at the medial
side of the tunnel of Corti, and three
Deiters’ cells at the lateral side but
not in the outer pillar cells (Fig. 4D).
Car14 was also weakly expressed in
the spiral ganglion region (Fig. 4C,
arrows). In the vestibule, weak Car14
expression was broadly observed in
the mesenchymal tissues in the vesti-
bule, but not in the otic capsule (Fig.
4A, bracket).
It was shown in the kidney that the
membrane-bound CAXIV (in rodents;
CAIV in humans) is expressed on the
luminal surface of the renal tube and
facilitates bicarbonate and fluid
transport by ion transporters such as
NBCI (Alvarez et al., 2003; Purkerson
and Schwartz, 2007). Previously, it
has been suggested that CO2 in the
outer hair cells is hydroxylated by
means of intracellular CA in the outer
hair cells, and exchanged to the endo-
lymph or diffused to the region
between the outer hair cells and Dei-
ters’ cells (Thalmann et al., 1970;
Kimura, 1975; Ikeda et al., 1992; Oka-
mura et al., 1996). Thus, it is also pos-
sible that CAII expressed in the outer
hair cells may cooperate with CAXIV
expressed on the extracellular surface
of Deiters’ cells to facilitate the
hydroxylation and transport of CO2,
which is the major product of high cel-
lular metabolism in the hair cells, and
play roles in optimal pH regulation
and fluid homeostasis in the organ of
Corti.
Fig. 4. Expression of Car14 in the developing mouse cochlea. A–C: Car14 was broadly expressed in both epithelial and mesenchymal tissues in
the cochlea and vestibule during embryonic and neonatal development. Car14 expression in the otic fibrocytes, Reissner’s membrane (A0, white
arrow), and stria vascularis (A0–C, arrowheads) at postnatal day (P) 0 and P5 became weaker at P21. Car14 was also expressed in the organ of
Corti in pillar cells and Deiters’ cells at P5 (B,B0). The inset in B0 showed Smpx expression in the hair cells. At P21, Car14 was expressed in the
inner phalangeal cells, inner pillar cells, and Deiters’ cells (C,D). The inset in D illustrates various cell types in the organ of Corti for comparison
with the Car14 expression domains. Car14 was also weakly expressed in the spiral ganglion (C, arrows). The scale bar in A applies to B and C;
the scale bar in D applies to B0.
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Acatalytic CA-related proteins
Car8 and Car11
An acatalytic CA-RP, Car8, was first
detected at P0 in the otic capsule near
the basal turn of the cochlear duct
and of the vestibule (Fig. 5A, arrow-
heads). This expression overlaps with
Pannexin 3 (Panx3), which is
expressed in the prehypertrophic
chondrocytes, perichondrium, and
osteoblasts (Fig. 5C, arrowheads)
(Iwamoto et al., 2010). At P5, Car8
expression in the otic capsule was
down-regulated, and was expressed
instead in the modiolus, which over-
laps with Panx3 (Fig. 5B,D, arrows).
Car8 transcripts were not detected in
the inner ear at P21, consistent with
the qRT-PCR results (Fig. 1). Based
on the developmental stage and ossifi-
cation pattern, it appears that Car8 is
expressed in prehypertrophic chon-
drocytes in the otic capsule at P0, and
later is expressed in differentiating
osteoblasts in the modiolus.
It is interesting that Car8 expres-
sion in the developing otic capsule
and modiolus overlaps with Panx3,
which is induced in prehypertrophic
chondrocytes and promotes chondro-
cyte and osteoblast differentiation.
Panx3 performs these roles as a Ca2þ
channel in the endoplasmic reticulum
(ER), as a hemichannel releasing ATP
into the extracellular space, and as a
gap junction propagating Ca2þ waves
between cells (Iwamoto et al., 2010;
Ishikawa et al., 2011). Panx3 as an
ER Ca2þ channel was activated simi-
lar to Inositol trisphosphate 3 recep-
tors (IP3Rs), which increase intracel-
lular Ca2þ levels upon IP3 binding to
and activating IP3Rs. Interestingly,
Car8 was shown to reduce the affinity
of IP3Rs for IP3 and inhibit increases
in intracellular calcium (Hirota et al.,
2003). Thus, it is possible that CAVIII
plays a role in forming the otic cap-
sule and modiolus by modulating IP3-
induced Ca2þ release during osteo-
blast differentiation. Although this
hypothesis remains to be tested, Car8
expression in the differentiating otic
capsule and modiolus is interesting
because only Car1 and Car2, which
are expressed in bone marrow cells in
otic capsule, have been known as
major carbonic anhydrases associated
with bone development (Lehenkari
et al., 1998; Rajachar et al., 2009).
Fig. 5. Expression of Car8 and Car11 in the developing mouse inner ear. A,B: Car8 was first
detected at postnatal day (P) 0 in the otic capsule by the basal turn of the cochlear duct and in
the vestibule (A, arrowheads). At P5, Car8 expression in the otic capsule was down-regulated
but instead expressed in the modiolus (arrows). C,D: Panx3 expression indicates prehypertro-
phic chondrocytes at P0 (C, arrowheads) and osteoblasts at P5 (D, arrows). E,F: Car11 was
broadly expressed in both epithelial and mesenchymal tissues of the inner ear and also in the
spiral ganglion at P5 (E, arrows). F,F0: At P21, Car11 was expressed in a similar broad pattern in
the spiral ganglion (F, arrows), Reissner’s membrane (black arrowhead), organ of Corti
(white arrowhead), bone marrow of the otic capsule (F0, arrows), and spiral prominence and the
associated root cell processes (bracket). Car11 was also weakly expressed in type I fibrocytes
(F0, asterisk). G,I: Supporting cells in the cristae and maculae expressed Car11 at P21. H,J:
Smpx was expressed in the hair cells of cristae and maculae at P21. Scale bar in A applies to
C, the scale bar in B applies to D, the scale bar in E applies to F, and the scale bar in G applies
to F0 and H–J.
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Another CA-RP, Car11, was broadly
expressed in the inner ear at P5, with
slightly stronger expression in the spi-
ral ganglion (Fig. 5E, arrows). At P21,
Car11 was expressed in the spiral gan-
glion (Fig. 5F, arrows), Reissner’s
membrane (Fig. 5F0, black arrowhead),
organ of Corti (Fig. 5F0, white arrow-
head), bone marrow of the otic capsule
(Fig. 5F0, arrows), spiral prominence,
and root cell processes (Fig. 5F0,
bracket). Car11 was also weakly
expressed in type I otic fibrocytes (Fig.
5F0, asterisk). In the vestibule, Car11
expression was observed in the apical
portion of cristae and maculae, most
likely in the supporting cells, based on
the comparison with the hair cell spe-
cific expression of Smpx (Fig. 5G–J).
Although CAXI immunoreactivity has
been shown in the developing and
mature human brain (Taniuchi et al.,
2002) and in gastrointestinal stromal
tumors (Morimoto et al., 2005), the
physiological roles of Car11 in the
mouse inner ear remains to be
elucidated.
Conclusions
In this study, we systemically sur-
veyed the expression patterns of tran-
scripts for all 16 known mammalian
CA isozymes throughout mammalian
inner ear development. Our data show
that not all isozymes are expressed,
and each isozyme has unique tempo-
ral and spatial expression patterns
during inner ear development, which
are summarized in Figure 6. The
expression patterns for some isozymes
closely overlapped with genes previ-
ously associated with inner ear devel-
opment or function, such as Pendrin,
Pou3f4, or Bmp4. In addition, we also
profiled the expression patterns of CA
isozymes in other organs, such as
brain, kidney, and liver from P21
mice, showing that each organ
expresses a unique combination of CA
isozymes, although some isozymes,
such as Car2 and Car14, appear to be
expressed ubiquitously (Fig. 1). These
expression patterns suggest that each
CA isozyme plays a unique role in
mammalian development and function
depending on its temporal and spatial
expression pattern.
EXPERIMENTAL
PROCEDURES
Tissue Dissection, RNA
Isolation, and cDNA
Synthesis
All animals were handled according
to the guidelines for the Care and Use
of Laboratory Animals of Yonsei Uni-
versity College of Medicine. The pro-
tocol for obtaining inner ear samples
was approved by the Committee on
Animal Research at Yonsei University
College of Medicine. The entire inner
ear tissues including the vestibule
and cochlea as well as surrounding
otic capsule were dissected at all
stages examined. Total RNA was
extracted using the RNeasy Mini kit
(Qiagen, Hilden, Germany) from
inner ear, brain, kidney, and liver tis-
sues dissected from C57BL/6 mice.
Fig. 6. A schematic diagram summarizing carbonic anhydrase isozyme expression during inner ear development. Transcripts of each CA isozyme
are illustrated at each developmental stage from embryonic day (E) 15.5 to postnatal (P) 21. Please refer to the text for details. CD, cochlear duct;
StV, stria vascularis; SV, scala vestibule; SM, scala media; ST, scala tympani; BM, basilar membrane; RM, Reissner’s membrane; OC, organ of
Corti; SP, spiral prominence; RC, root cell processes; I, type I fibrocyte; II, type II fibrocyte; III, type III fibrocyte; IV, type IV fibrocyte; V, type V
fibrocyte.
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RNase-free DNase was used to digest
of genomic DNA during RNA purifica-
tion (Qiagen, Hilden, Germany). The
concentration and purity of the
extracted RNAs were determined
using both the spectrophotometric
method at 260 and 280 nm and RNA
electrophoresis. One microgram of
total RNA was subjected to reverse
transcription with oligod(T)19 primer
using the High Capacity cDNA
Reverse Transcription Kit (Applied
Biosystems, Foster City, CA).
Semi-quantitative Reverse
Transcription PCR Analysis
Synthesized cDNAs were subjected to
semi-quantitative RT-PCR to analyze
relative expression levels of CA iso-
zymes among tissues. CA isozyme spe-
cific PCR primers previously reported
were used for RT-PCR (Lacruz et al.,
2010). PCR conditions were as follows:
28 cycles of denaturation at 94C for 20
sec, annealing at 55C for 40 sec, and
extension at 72C for 40 sec. The first
denaturation step and the last exten-
sion step were performed at 95C for
15 min and 72C for 5 min, respec-
tively. PCR products were separated
and visualized on a 2% agarose gel.
Quantitative Real-Time PCR
qRT-PCR was performed to analyze
the expression of each CA isozyme
during inner ear development at
E15.5, P0, P5, and P21. RNA purified
from three replicates of each inner
ear sample was used for qRT-PCR.
PCR primers were designed based on
mRNA sequences in the GenBank
database (Table 1). Forward and
reverse primers from each primer set
were designed from different exons to
distinguish transcripts from genomic
DNA. GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) was used
as an internal control for normaliza-
tion. qRT-PCR for each CA isozyme
was performed in triplicate using
SYBR Green PCR Master Mix and
the Applied Biosystems StepOnePlus
Real-Time PCR Systems (Applied Bio-
systems). A melting curve analysis
was always performed after the
amplification to check PCR specificity.
The results were analyzed by Ste-
pOne Software v2.1 (Applied Biosys-
tems). The normalization and relative
quantification were calculated using
2DDCt method (Livak and Schmitt-
gen, 2001).
In Situ Hybridization
For E15.5 embryos and neonatal (P0
and P5) pups, animals were killed by
decapitation and then hemi-sectioned.
After removing the brain, the speci-
mens were fixed in 4% paraformalde-
hyde in phosphate buffered saline
(PBS) overnight at 4C, dehydrated in
30% sucrose in PBS overnight at 4C,
embedded in OCT compound (Sakura,
Tokyo, Japan), and stored at 80C
until use. For P21 mice, the entire
inner ear tissues including the otic
capsule were dissected. For better
penetration of fixatives, parts of the
semicircular canals were cut off, the
oval and round windows were opened
up, and the apex of the cochlea was
punctured. After overnight fixation,
the specimens were decalcified in 0.2
M EDTA in DEPC-PBS at 4C for 2
days, followed by dehydration and
mounting. Tissues were sectioned at
12 mm thickness for in situ hybridiza-
tion, which was performed as previ-
ously described (Morsli et al., 1998).
At least three animals were tested for
each CA isozyme at each developmen-
tal stage. Sense RNA probes were also
included as controls, which showed no
signal anywhere in the inner ear.
Probes for Bmp4 (Morsli et al.,
1998), Pou3f4 (Phippard et al., 1998),
Smpx (Yoon et al., 2011), and Pendrin
(Everett et al., 1999) were prepared
as previously described. RNA probes
for Car1 were generated from a 381
base pair (bp) mouse Car1 cDNA con-
taining the þ594 to þ786 coding
region and the 188 bp 30 untraslated
region (NM_009799.4); for Car2, from
a 410 bp mouse Car2 cDNA contain-
ing the þ654 to þ783 coding region
and the 280 bp 30untranslated region
(NM_009801.4); for Car3, from a 404
TABLE 1. Primer Sequences for Quantitative Real-Time PCR
Gene Forward primer (50-30) Reverse primer (50-30)
Product size(bp)
cDNA gDNA
Gapdh GGTGCTGAGTATGTCGTGGA CTAAGCAGTTGGTGGTGCAG 202 300
Car1 GCAAGTGCAGACTGGGGATA TGGAAAGAATGTCCCACGTT 200 621
Car2 TGAAAGGAGGACCCCTCAGT AATACCCAAAACAGCCAATCC 200 594
Car3 GAGAAAGGCGAGTTCCAGATT AGCTCACAGTCATGGGCTCT 202 946
Car4 CTTCATCCTCGTCGGCTATG ATGGCAAAGTGTCTCCCATC 204 803
Car5a GCCTCTGGGAAACCACTACA TTCAGAAACACGCCGATGAC 201 3421
Car5b ACAGAAATTGGTGGACACTTTG CTGGTCACGGTCAACCTCAA 196 1292
Car6 CCCCTGAGCTTGGTGAACTA TGATCCCATCAATGGTGTGT 202 834
Car7 ACCTATCCTGGCTCCCTGAC AAGGATGCTTTGACCACTCG 203 667
Car8 GGAACATGTTGGCTTGAAGG AAAGGGTATCGGAATAATATCCA 198 2359
Car9 ATCACCCAGGCTCAGAACAC TTTCTTCCAAATGGGACAGC 198 1266
Car10 TCACTTATGATGGGTCGATGA TGGTGCGAATACAGCGATTA 201 2157
Car11 TCTCCTTCCTACCTGCATCC GCAGCACTGAGGTTCCCATA 202 415
Car12 CGCCAATCCATCATATGACAA GAAATCTGCACAGGGTTTCG 204 484
Car13 TGCATGTTGTCCACTGGAAT AGCAAGCATAACGGGTCAAA 202 2068
Car14 GCTACAACGGCTCACTCACA AAGCAAAGATGGTCCTCTGG 198 284
Car15 CGGTGCTCTGGACTGTCTTT GGGCAGGGTAGAGACTGATG 203 299
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bp mouse Car3 cDNA containing the
þ687 to þ783 coding region and the
334 bp 30 untranslated region
(NM_007606.3); for Car8, from a
621 bp mouse Car8 cDNA containing
the þ212 to þ832 coding region and
the 12 bp 50 untranslated region
(NM_007592.3); for Car12, from a 471
bp mouse Car12 cDNA containing the
þ947 to þ1,065 coding region and the
352 bp 50 untranslated region
(NM_178396.4); for Car13, from a 404
bp mouse Car13 cDNA containing the
þ664 to þ789 coding region and the
278 bp 50 untranslated region
(NM_024495.5); for Car14, from a 856
bp mouse Car14 cDNA containing the
þ1 to þ821 coding region and the 35 bp
50 untranslated region (NM_011797.2);
for Car11, from a 916 bp mouse Car11
cDNA containing 634 bp coding region
and the 282 bp 50 untranslated region
(NM_009800.4); for Osteocalcin, from a
33 bp mouse Osteocalcin cDNA con-
taining the 47 bp 50 untranslated
region and the entire open reading
frame (NM_007541.2); for Pannexin3,
from a 559 bp mouse Pannexin3 cDNA
containing the þ565 to þ1,123 coding
region (NM_172454.2).
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